New pharmacological tools:the use of diterpenes to promote adult hippocampal neurogenesisRicardo Gómez-Oliva,Pedro Nunez-Abades,Carmen Castro1629-1630
Clustering of voltage-gated ion channels as an evolutionary trigger of myelin formationHenrike Ohm,Simone Rey,Christian Klämbt1631-1632
Using microglia-derived extracellular vesicles to capture diversity of microglial activation phenotypes following neurological injuryAustyn D.Roseborough,Nikita Ollen-Bittle,Shawn N.Whitehead1633-1634
Sexual dimorphism of G protein-coupled receptor signaling in the brainSara Aljoudi,Hamdan Hamdan,Khaled S.Abd-Elrahman1635-1636
Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucomaPete A.Williams,Robert J.Casson1637-1638
MAP4K inhibition as a potential therapy for amyotrophic lateral sclerosisShuaipeng Ma,Chun-Li Zhang1639-1640
Role of fullerenols derivative 3HFWC in the treatment of Alzheimer's diseaseSanja Ivkovic,Djuro Koruga1641-1642
Monomeric C-reactive protein:a link between chronic inflammation and neurodegeneration?Nicoleta Arnaut,Ylenia Pastorello,Mark Slevin1643-1644
Alterations of protein homeostasis in Alzheimer's disease:beyond Procrustean bed of endoplasmic reticulum stress and unfolded protein responseDmitry Lim,Alexei Verkhratsky1645-1646
The big data challenge-and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyondSven Marcel Stefan,Muhammad Rafehi1647-1648